Experienced in DFNB1

Francesco M. Semeraro

Brescia, IT 
Experienced in DFNB1
Brescia, IT 
OverviewLocationsClinical Research

Overview

Francesco Semeraro practices in Brescia, Italy. Mr. Semeraro is rated as an Experienced expert by MediFind in the treatment of DFNB1. His top areas of expertise are Diabetic Retinopathy, Fuchs Dystrophy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Corneal Transplant.

His clinical research consists of co-authoring 210 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of DFNB1.

Gender
Male

Locations

Brescia, Italy
Other Locations
Chieti, Italy
Bologna, Italy
Bari, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3

210 Total Publications

Validation of a Deep Learning-Assisted Evaluation of Total Corneal Endothelial Cells Viability.
Validation of a Deep Learning-Assisted Evaluation of Total Corneal Endothelial Cells Viability.
Journal: Translational vision science & technology
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Semeraro's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile